Ramachandran Lintu, Dontaraju Venkata S, Patel Kushal
Internal Medicine, Javon Bea Hospital, Rockford, USA.
Cureus. 2020 Dec 4;12(12):e11896. doi: 10.7759/cureus.11896.
The efficacy of over the counter probiotics has been an area of scientific debate. While the benefits of probiotics are heavily disputed, probiotics are considered generally safe. We present a case of a liver cirrhosis patient, who presented with hepatic encephalopathy. The patient was taking daily probiotics and receiving weekly therapeutic paracentesis. His workup revealed spontaneous bacterial peritonitis (SBP). Despite starting the patient on empiric ceftriaxone and vancomycin, the patient's leukocytosis did not improve. The paracentesis fluid and blood cultures grew . Antibiotics were switched to piperacillin/tazobactam, after which the patient improved clinically. The case highlights the importance of vigilance in using probiotics, especially in liver cirrhosis patients. Also, patients with Lactobacillus-associated SBP may not improve with empiric antibiotic treatment of cephalosporins.
非处方益生菌的功效一直是科学争论的一个领域。虽然益生菌的益处备受争议,但益生菌通常被认为是安全的。我们报告一例肝硬化患者,该患者出现肝性脑病。患者每日服用益生菌并每周接受治疗性腹腔穿刺术。其检查发现自发性细菌性腹膜炎(SBP)。尽管开始让患者经验性使用头孢曲松和万古霉素,但患者的白细胞增多症并未改善。腹腔穿刺液和血培养生长出……抗生素换用哌拉西林/他唑巴坦后,患者临床症状改善。该病例凸显了使用益生菌时保持警惕的重要性,尤其是在肝硬化患者中。此外,乳酸杆菌相关性SBP患者可能无法通过经验性使用头孢菌素类抗生素治疗而改善。